Leading Industry Experts to Present at Lonza’s 2nd Global Endotoxin Testing Summit
News Mar 01, 2016
Returning to the line-up is Lonza Senior Scientist Kevin Williams. With more than 30 years of hands-on experience in the area of pharmaceutical quality control, Williams is a recognized expert in the field of endotoxin detection. In addition, Johannes Reich of Hyglos GmbH will return to the event to provide an update on his theory behind the underlying mechanism of Low Endotoxin Recovery (LER).
Lakiya Wimbish, Lonza Product Manager Endotoxin Detection, commented, “With these two speakers and other world-class industry thought leaders attending and presenting at the 2nd Global Endotoxin Testing Summit, the event will provide an opportunity for QC Directors, lab managers, key opinion leaders, users and regulators to discuss current issues within the endotoxin detection industry and to make progress in improving pharmaceutical safety.”
The 2nd Global Endotoxin Testing Summit agenda will address industry hot topics ranging from endotoxin testing basics to regulatory guidance updates and Low Endotoxin Recovery. The summit will also cover the use and relevance of naturally occurring endotoxin (NOE) in hold-time studies, explore new opportunities for process optimization and discuss ways to address variability associated with the kinetic chromogenic assay.
More than 60 years after the drug thalidomide caused birth defects in thousands of children whose mothers took the drug while pregnant, scientists have solved a mystery that has lingered ever since the dangers of the drug first became apparent: how did the drug produce such severe fetal harm?READ MORE
Hereditary angioedema (HAE) is a rare genetic disorder characterized by recurrent painful swellings of the skin and mucous membranes. A new drug has been developed to help prevent attacks of hereditary angioedema. It has now been investigated in an international study performed at over 26 university facilities in Europe, Canada and Australia.READ MORE